Science and Technology Committee (Commons)

Balance and effectiveness of research and innovation spending inquiry

Inquiry status: open - accepting written submissions

Scope of the inquiry

In May 2018, UK Research & Innovation (UKRI) published its Strategic Prospectus, which represents “the beginning of the process to develop a detailed Research and Innovation Strategy”. It states that “We will work with Government to develop a plan for meeting this target [to increase the UK’s investment in research and development to 2.4% of GDP by 2027, and in the future to 3%], maximising the impact of public investment in research and innovation, and supporting business and other partners to invest more.” It envisages ongoing work on “what constitutes reasonable balance” of its funding.

The deadline for written submissions is Friday 28 September 2018.

Terms of reference: Balance and effectiveness of research and innovation spending Send a written submission

Latest evidence

  • 18 Dec 2018 - Balance and effectiveness of research and innovation spending - oral evidence | PDF version (PDF342 KB) HC 1453 | Published 17 Jan 2019

    Evidence given by Keith Thompson, Chair, Catapult CEO network, and CEO, Cell and Gene Therapy Catapult, Professor Richard Brook, President, Association of Innovation, Research & Technology Organisations, David Connell, Senior Research Fellow, Centre for Business Research, Cambridge Judge Business School, and Felicity Burch, Director of Innovation and Digital, Confederation of British Industry; Dr Robert Massey, Deputy Executive Director, Royal Astronomical Society, Professor Dame Ann Dowling, President, Royal Academy of Engineering, Professor Neil Hall, Director, Earlham Institute, and Dr Charmaine Griffiths, Chief Operating Officer, The Institute of Cancer Research

    Watch this evidence session

Next meeting(s)

There are currently no public meetings scheduled.

Receive RSS updates

Share this page